思创医惠发布前三季度业绩，净亏损476.22万元

Core Insights - The company reported a revenue of 604 million yuan for the first three quarters of 2025, representing a year-on-year growth of 6.95% [1] - The net loss attributable to shareholders of the listed company was 4.76 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 158 million yuan [1]